Effectiveness of internet-delivered cognitive behavioural therapy in reducing sickness absence among young employees with depressive symptoms: study protocol for a large-scale pragmatic randomised controlled trial

Anne Kouvonen Piotrowska , Minna Mänty , Jaakko Harkko , Hilla Sumanen , Hanna Konttinen , Jouni Lahti , Olli Pietiläinen , Jenni Blomgren , Eevamaija Tuovinen , Eeva-Leena Ketonen , Jan-Henry Stenberg , Michael Donnelly , Børge Sivertsen , Ellenor Mittendorfer-Rutz , Sami Pirkola , Ossi Rahkonen , Tea Lallukka

Abstract

Introduction Depression is a highly prevalent condition with typical onset in early adulthood. Internet-delivered cognitive behavioural therapy (iCBT) is a promising cost-effective and more widely available alternative to face-to-face CBT. However, it is not known whether it can reduce sickness absence in employees showing depressive symptoms. The randomised controlled trial component of the DAQI (Depression and sickness absence in young adults: a quasi-experimental trial and web-based treatment intervention) project aims to investigate if iCBT is effective in reducing sickness absence compared with care as usual (CAU) among young employees with depressive symptoms in primary care provided in an occupational health setting. Methods and analysis This study will use a randomised controlled single-centre service-based trial of an existing iCBT programme (Mental Hub iCBT for Depression) to evaluate whether or not this treatment can reduce the number of sickness absence days in public sector employees aged 18–34 years who present at the occupational health service with mild depressive symptoms (score ≥9 on the Beck Depression Inventory-IA). Control participants will be offered CAU, with no constraints regarding the range of treatments. The active condition will consist of seven weekly modules of iCBT, with support from a web therapist. Primary outcome will be participants’ all-cause sickness absence as indicated in employer’s and national administrative records up to 6 months from study entry. Secondary outcomes relating to long-term sickness absence (over 11 calendar days) for mental and musculoskeletal disorders and psychotropic medication use will be obtained from the Finnish Social Insurance Institution’s administrative records; and short sickness absence spells (up to 11 calendar days) will be extracted from employer’s records. Analyses will be conducted on an intention-to-treat basis.
Author Anne Kouvonen Piotrowska (Filia we Wrocławiu)
Anne Kouvonen Piotrowska,,
- Filia we Wrocławiu
, Minna Mänty
Minna Mänty,,
-
, Jaakko Harkko
Jaakko Harkko,,
-
, Hilla Sumanen
Hilla Sumanen,,
-
, Hanna Konttinen
Hanna Konttinen,,
-
, Jouni Lahti
Jouni Lahti,,
-
, Olli Pietiläinen
Olli Pietiläinen,,
-
, Jenni Blomgren
Jenni Blomgren,,
-
, Eevamaija Tuovinen
Eevamaija Tuovinen,,
-
, Eeva-Leena Ketonen
Eeva-Leena Ketonen,,
-
et al.`
Journal seriesBMJ Open, ISSN 2044-6055, (N/A 100 pkt)
Issue year2019
Vol9
No10
Pages1-9
Publication size in sheets0.5
Article numbere032119
ASJC Classification2712 Endocrinology, Diabetes and Metabolism
DOIDOI:10.1136/bmjopen-2019-032119corr1
URL https://bmjopen.bmj.com/content/9/10/e032119
Languageen angielski
File
Effectiveness_tekst.pdf 670.17 KB
Effectiveness_oswiadczenie.pdf 665.01 KB
Score (nominal)100
Score sourcejournalList
Publication indicators Scopus SNIP (Source Normalised Impact per Paper): 2018 = 1.145; WoS Impact Factor: 2018 = 2.376 (2) - 2018=2.863 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back
Confirmation
Are you sure?